The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients
ASAMET试验:一项随机、II期、双盲、安慰剂对照、多中心、2×2析因生物标志物研究,旨在评估低剂量阿司匹林和二甲双胍对I-III期结直肠癌患者的三级预防作用。
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-018-5126-7
Petrera, Marilena; Paleari, Laura; Clavarezza, Matteo; Puntoni, Matteo; Caviglia, Silvia; Briata, Irene Maria; Oppezzi, Massimo; Mislej, Eva Mihajlovic; Stabuc, Borut; Gnant, Michael; Bachleitner-Hofmann, Thomas; Roth, Wilfried; Scherer, Dominique; Haefeli, Walter-E; Ulrich, Cornelia M; DeCensi, Andrea